Effects of repeated administration of L-DOPA and apomorphine on circling behavior and striatal dopamine formation

Brain Research

Volumn 784, Issue 1-2, 1998, Pages 148-153

  Brannan, Timothy ^a,b,c   Prikhojan, Alla ^a   Yahr, Melvin D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Neurology   (United States)

^c JERSEY CITY MEDICAL CENTER   (United States)

Author keywords

Brain microdialysis; Dopamine; L DOPA; Parkinson's disease; Repeated administration

Indexed keywords

APOMORPHINE; DOPAMINE; LEVODOPA; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG SCREENING; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; APOMORPHINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; ELECTROCHEMISTRY; LEVODOPA; MALE; MICRODIALYSIS; NEOSTRIATUM; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA;

EID: 0032536478     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01191-8     Document Type: Article

References (20)

1. Brannan T., Martínez-Tica J., Yahr M.D. Effect of dietary protein on striatal dopamine formation following L-DOPA administration: An in vivo study. Neuropharmacology. 30:1991;1125-1127.
2. Brannan T., Martínez-Tica J., Yahr M.D. Catechol-O-methyltransferase inhibition increases striatal L-DOPA and dopamine: An in vivo study in rats. Neurology. 42:1992;683-685.
3. Brannan T., Martínez-Tica J., Yahr M.D. Changes in body temperature markedly affect striatal dopamine release and metabolism: An in vivo study. J. Neural Transm. [Genl. Sect.]. 89:1992;193-196.
4. Castro R., Abreu P., Calzadilla C.H., Rodriguez M. Increased or decreased locomotor response in rats, following repeated administration of apomorphine depends on dosage interval. Psychopharmacology. 85:1982;333-339.
5. Davis T.L., Brughitta G., Baronti F., Mouradian M.M. Acute effects of pulsatile levodopa administration of central dopamine pharmacodynamics. Neurology. 41:1991;630-633.
6. Frankel J.P., Pirtosek Z., Kempster P.A., Bovingdon M., Webster R., Lees A.J., Stern G.M. Diurnal differences in response to oral levodopa. J. Neurol. Neurosurg. Psychiat. 53:1990;948-950.
7. Gancher S.T., Nutt J.G. Diurnal responsiveness to apomorphine. Neurology. 37:1987;1250-1253.
8. Grace A.A., Bunney B.S. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording. J. Pharmacol. Exp. Ther. 238:1986;1092-1100.
9. Grandas F., Gancher S.T., Rodriguez M., Lera G., Nutt J.G., Obeso J.A. Differences in the motor response to apomorphine between untreated and fluctuating patients with Parkinson's disease. Clin. Neuropharmacol. 15:1992;13-18.
10. Grandas F., Obeso J.A. Motor responses following repeated apomorphine administration is reduced in Parkinson's disease. Clin. Neuropharmacol. 12:1989;14-22.
11. Hefti F., Melamed E., Wurtman R.J. Partial lesions of the dopaminergic system in rat brain: biochemical characterization. Brain Res. 195:1980;123-137.
12. Hughes A.H., Bishop S., Stern G., Lees A.J. The motor response to repeated apomorphine administration in Parkinson's disease. Clin. Neuropharmacol. 14:1991;209-213.
13. Hughes A.H., Lees A.J., Stern G.M. The motor response to sequential apomorphine in Parkinsonian fluctuations. J. Neurol. Neurosurg. Psychiatry. 54:1991;358-360.
14. Kempster P.A., Frankel J.P., Stern G.M., Lees A.J. Comparison of motor response to apomorphine and levodopa in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry. 53:1990;1004-1007.
15. Mena I., Cotzias G.C. Protein intake and treatment of Parkinson's disease with levodopa. New Engl. J. Med. 310:1975;483-488.
16. Nutt J.G., Holford N.H.G. The response to levodopa in Parkinson's disease: Imposing pharmacological law and order. Ann. Neurol. 39:1996;561-573.
17. Obeso J.A., Luquin M.R., Grandas F., Vaamonde J., Laguna J., Martinez-Lage J.M. Motor response to repeated dopaminergic stimulation in Parkinson's Disease. Clin. Neuropharmacol. 15:1992;75-79.
18. Sage J.I., Mark M.H. The rationale for continuous dopaminergic stimulation in patients with Parkinson's disease. Neurology. 42(Suppl. 1):1992;23-28.
19. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. 367(suppl):1971;69-91.
20. Yahr M.D. Variations in the 'on-off' effect. Adv. Neurol. 5:1974;397-399.